The Romiplostin for Injection, cataloged under National Stock Number 6505-01-697-1709, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Amgen Inc.. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: EA.
| Parameter | Value |
|---|---|
| NSN | 6505-01-697-1709 |
| Primary Part Number | NDC55513-0222-01 |
| Item Name | Romiplostin for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Amgen Inc. |
| Status | ACTIVE |
| Administration | SUBCUTANEOUS |
| Primary Container Content Quantity | 500.0 MICROGRAMS OF ACTIVE INGREDIENT |
| Primary Container Type | VIAL |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| Total Primary Container Quantity | 1 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | EA |
| Part Number | Manufacturer |
|---|---|
| NDC55513-0222-01 | Dms Pharmaceutical Group Inc (USA) |
| NDC55513-0222-01 PRIMARY | Amgen Inc. (USA) |
| Reference | Meaning |
|---|---|
| NDC55513-0222-01 | 5/9 Secondary reference Walgreens Specialty Pharmacy, Llc |
| 1598733 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM217322 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-697-1709 is a Romiplostin for Injection, manufactured by Amgen Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-697-1709 has 2 manufacturer part numbers on file: NDC55513-0222-01 (Dms Pharmaceutical Group Inc), NDC55513-0222-01 (Amgen Inc.).
Key specifications for NDC55513-0222-01: Administration: SUBCUTANEOUS; Primary Container Content Quantity: 500.0 MICROGRAMS OF ACTIVE INGREDIENT; Primary Container Type: VIAL; Special Features: 500MCG SDV; 1 ML VIAL. NPLATE ROMIPLOSTIM IS A THROMBOPOIETIN RECEPTOR AGONIST INDICATED FOR THE TREATMENT OF THROMBOCYTOPENIA. STORE AT 2 TO 8C. PROTECT FROM LIGHT. DO NOT FREEZE.. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.